Partridge E

No ORCID on file · 3 papers in corpus
2016
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.08.334

BackgroundThe Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4years of follow-up. The UKCTOCS screening trial failed to show a s…

2014
Assessing needs and assets for building a regional network infrastructure to reduce cancer related health disparities.
Evaluation and program planning ·doi:10.1016/j.evalprogplan.2013.12.003

Significant cancer health disparities exist in the United States and Puerto Rico. While numerous initiatives have been implemented to reduce cancer disparities, regional coordination of these efforts between institutions is often limited. T…

2012
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.12.440

ObjectiveTo determine whether CA-125 velocity is a statistically significant predictor of ovarian cancer and develop a classification rule to screen for ovarian cancer.MethodsIn the ovarian component of the PLCO cancer screening trial, 28,0…